In this expert webinar, leading thoracic surgeons from the US, Japan, and Germany examine the ongoing debate between segmentectomy and lobectomy for early-stage lung cancer.
Prof. Peter Kneuertz (Ohio State University Wexner Medical Center) and Prof. Meinoshin Okumura (Osaka University) join moderator Prof. Dr. med. Servet Bölükbas (University Hospital Essen – Ruhrlandklinik, Germany) to discuss current clinical evidence, patient selection criteria, oncologic outcomes, and how surgeons are approaching surgical decision-making in 2026.
Topics covered include anatomical vs. sublobar resection, recurrence risk, pulmonary function preservation, and evolving guidelines.
Presented by Lexington Medical in collaboration with IRCAD and WebSurg.
What You’ll Learn
- How recent 10-year data is shifting the surgical paradigm for early-stage lung cancer away from generalized equivalence and toward a cautious, highly selective patient approach.
- The critical criteria for a patient-centered approach when choosing between segmentectomy and lobectomy, supported by clinical perspectives and practices from both the United States and Japan.
- The historical context, ongoing surgical evolution, and future trajectory of segmentectomy for early-stage non-small-cell lung cancer.
